Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;10(3):575.
doi: 10.3390/biomedicines10030575.

Placental Insulin Receptor Transiently Regulates Glucose Homeostasis in the Adult Mouse Offspring of Multiparous Dams

Affiliations

Placental Insulin Receptor Transiently Regulates Glucose Homeostasis in the Adult Mouse Offspring of Multiparous Dams

Grace Chung et al. Biomedicines. .

Abstract

In pregnancies complicated by maternal obesity and gestational diabetes mellitus, there is strong evidence to suggest that the insulin signaling pathway in the placenta may be impaired. This may have potential effects on the programming of the metabolic health in the offspring; however, a direct link between the placental insulin signaling pathway and the offspring health remains unknown. Here, we aimed to understand whether specific placental loss of the insulin receptor (InsR) has a lasting effect on the offspring health in mice. Obesity and glucose homeostasis were assessed in the adult mouse offspring on a normal chow diet (NCD) followed by a high-fat diet (HFD) challenge. Compared to their littermate controls, InsR KOplacenta offspring were born with normal body weight and pancreatic β-cell mass. Adult InsR KOplacenta mice exhibited normal glucose homeostasis on an NCD. Interestingly, under a HFD challenge, adult male InsR KOplacenta offspring demonstrated lower body weight and a mildly improved glucose homeostasis associated with parity. Together, our data show that placenta-specific insulin receptor deletion does not adversely affect offspring glucose homeostasis during adulthood. Rather, there may potentially be a mild and transient protective effect in the mouse offspring of multiparous dams under the condition of a diet-induced obesogenic challenge.

Keywords: fetal programming; gestational diabetes; multiparity; obesity; placental insulin receptor; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Newborn offspring with placenta-specific InsR ablation presented with normal body weight and pancreatic β-cell mass. (A) Experimental schematic for generating InsR KOplacenta and littermate controls. (B) GFP reporter (Cyp19-cre; CAG+/+) expressing endogenous green fluorescence (GFP) in a mouse embryonic E17.5 placenta section compared to the non-GFP control (CAG+/+) (scale bars: 500 μm). (C) InsR mRNA expression in the E17.5 InsR KOplacenta compared to controls by quantitative reverse transcription polymerase chain reaction (qPCR) (n = 12, 13). (D) Histology of the E17.5 male control placentas (left) compared to InsR KOplacenta (right) (scale bars: 500 μm). Background of images was subtracted post-imaging. (E) Gross morphology of the male and (E’) female control (left) and the InsR KOplacenta (right) newborn pancreata. (F) Whole pancreatic sections (scale bars: 500 μm) of the male newborn control (left) and the InsR KOplacenta (right) mice immunostained for insulin-positive islets (green) and DAPI (blue). Single islet β-cells (scale bars: 50 μm) shown as insets. Single islet images were cropped post-imaging to highlight the single islet. (G) Beta cell mass for the male (n = 5) and (G’) female (n = 5) newborns. The values are reported as the means ± SEM, ** p <0.01. E: embryonic; P: postnatal; BW: body weight; BG: blood glucose; IPGTT: intraperitoneal glucose tolerance test; IPITT; intraperitoneal insulin tolerance test; NCD: normal chow diet.
Figure 2
Figure 2
Adult InsR KOplacenta mice displayed normal glucose homeostasis on a normal chow diet. (A) Body weight in all the males (n = 9, 10) and (A’) the female (n = 13) InsR KOplacenta and control mice on a normal chow diet. Body weight for the offspring presented as combined data from parity ≥ 3 and ≤2 litters. (B) IPGTT and AUC analysis (right) for the male (n = 4) and (B’) female (n = 4) mice from parity ≥ 3 on a normal chow diet at 9 weeks of age. (C) IPITT and AUC analysis (right) for the males (n = 4) and (C’) females (n = 4) from parity ≥ 3 at 11 weeks of age. Blood glucose values for IPITT are expressed as the baseline percentage of blood glucose. The values are reported as the means ± SEM, * p < 0.05.
Figure 3
Figure 3
Adult male InsR KOplacenta offspring demonstrated lower body weight under a high-fat diet challenge. (A) Schematic of experimental design for a high-fat diet (HFD). (B) Body weight monitored in all the males (n = 6, 7) and (B’) females (n = 8, 9) from parity ≥ 3 and ≤2 across 17 weeks on a HFD. (C) Non-fasting blood glucose levels for all the males (n = 6, 7) and (C’) females (n = 8, 9) from parity was ≥3 and ≤2 (measured across 17 weeks on a HFD). Measurements not included for T = 4, 8, 10, 14, and 18 weeks on a HFD due to phenotyping performed on these weeks. (D) Fasting blood glucose measured for the males (n = 4, 7) and (D’) females (n = 4, 9) from parity ≥ 3 and ≤2 at 4, 8, and 10 weeks on a HFD. (E) Fat mass for the males (n = 6, 7) and (E’) females (n = 8, 9) from parity ≥ 3 and ≤2 as assessed by EchoMRI at 18–19 weeks on a HFD. (F) Lean mass for the males (n = 6, 7) and (F’) females (n = 8, 9) from parity ≥ 3 and ≤2 as assessed by EchoMRI at 18–19 weeks on a HFD. (G) Pancreas weight for the males (n = 6, 7) and (G’) females (n = 8, 9) from parity ≥ 3 and ≤2 upon harvest at 19–20 weeks on a HFD. The values are reported as the means ± SEM, * p < 0.05. P: postnatal; BW: body weight; BG: blood glucose; IPGTT: intraperitoneal glucose tolerance test; IPITT; intraperitoneal insulin tolerance test; HFD: high-fat diet.
Figure 4
Figure 4
Adult male InsR KOplacenta mice from multiparous dams presented with a mild and transient improved glucose homeostasis on a high-fat diet challenge. (A) IPGTT and AUC analysis (right) for the male (n = 4) and (A’) female (n = 4) mice from parity ≥ 3 at 8 weeks on a HFD. Repeated measures two-way ANOVA revealed significant differences (p = 0.0332) between the InsR KOplacenta and control males at 8 weeks on a HFD. A separate unpaired t-test performed specifically for T = 60 min revealed p = 0.0593. (B) IPITT and AUC analysis (right) for the males (n = 4) and (B’) females (n = 4) from parity ≥ 3 at 14 weeks on a HFD. Blood glucose values for IPITT are expressed as the baseline percentage of blood glucose. Repeated measures two-way ANOVA analysis revealed a p-value of 0.0867 in the males at 14 weeks on a HFD. A separate unpaired t-test performed specifically for T = 30 and T = 60 min revealed p = 0.0843 and p = 0.0600, respectively. The values are reported as the means ± SEM, * p < 0.05.

Similar articles

Cited by

References

    1. Singh G.K., DiBari J.N. Marked disparities in pre-pregnancy obesity and overweight prevalence among US women by race/ethnicity, nativity/immigrant status, and sociodemographic characteristics, 2012–2014. J. Obes. 2019;2019:2419263. doi: 10.1155/2019/2419263. - DOI - PMC - PubMed
    1. DeSisto C.L., Kim S.Y., Sharma A.J. Prevalence estimates of gestational diabetes mellitus in the United States, pregnancy risk assessment monitoring system (PRAMS), 2007–2010. Prev. Chronic Dis. 2014;11:E104. doi: 10.5888/pcd11.130415. - DOI - PMC - PubMed
    1. Zhu Y., Zhang C. Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: A Global Perspective. Curr. Diabetes Rep. 2016;16:7. doi: 10.1007/s11892-015-0699-x. - DOI - PMC - PubMed
    1. Friedman J.E. Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed? Diabetes. 2018;67:2137–2151. doi: 10.2337/dbi17-0011. - DOI - PMC - PubMed
    1. Harmon H.M., Hannon T.S. Maternal obesity: A serious pediatric health crisis. Pediatr. Res. 2018;83:1087–1089. doi: 10.1038/pr.2018.50. - DOI - PubMed